Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
NN Inc
NNBR
$301M
| $309K | ﹤0.01% |
136,702
| – | – |
|
3202
InfuSystem Holdings
INFU
$245M
| $309K | ﹤0.01% |
57,378
| – | – |
|
3203
Rentokil
RTO
$12.5B
| $308K | ﹤0.01% |
13,428
-21,438
| -61% | -$517K |
|
3204
Valhi
VHI
$408M
| $307K | ﹤0.01% |
18,903
| – | – |
|
3205
Everspin Technologies
MRAM
$378M
| $303K | ﹤0.01% |
59,475
+192
| +0.3% | +$1.11K |
|
|
CMRX
3206
DELISTED
Chimerix, Inc.
CMRX
| $302K | ﹤0.01% |
35,437
-17,220
| -33% | -$95K |
|
3207
Townsquare Media
TSQ
$114M
| $301K | ﹤0.01% |
37,030
-3,700
| -9% | -$32.2K |
|
|
AFCG
3208
AFC Gamma
AFCG
$63.4M
| $301K | ﹤0.01% |
53,954
+3,533
| +7% | +$28.1K |
|
3209
Sera Prognostics
SERA
$78.3M
| $299K | ﹤0.01% |
81,230
+2
| +0% | +$10 |
|
3210
Purple Innovation
PRPL
$40.3M
| $297K | ﹤0.01% |
15,669
-1,731
| -10% | -$39.9K |
|
|
MAPS
3211
DELISTED
WM TECHNOLOGY INC A
MAPS
| $294K | ﹤0.01% |
259,858
+22,343
| +9% | +$29.8K |
|
3212
American Vanguard Corp
AVD
$73.2M
| $293K | ﹤0.01% |
66,623
-76,246
| -53% | -$389K |
|
3213
Future Fuel
FF
$217M
| $292K | ﹤0.01% |
74,851
+37
| +0% | +$178 |
|
3214
Taylor Devices
TAYD
$170M
| $289K | ﹤0.01% |
8,964
| – | – |
|
3215
Stratus Properties
STRS
$159M
| $289K | ﹤0.01% |
16,282
| – | – |
|
|
NOVA
3216
DELISTED
Sunnova Energy
NOVA
| $287K | ﹤0.01% |
772,043
-136,954
| -15% | -$264K |
|
|
KWY
3217
Kingsway Corp
KWY
$262M
| $286K | ﹤0.01% |
36,084
| – | – |
|
3218
Atossa Therapeutics
ATOS
$23.8M
| $284K | ﹤0.01% |
28,172
+8,062
| +40% | +$97.9K |
|
|
ARIS
3219
Aris Mining
ARIS
$3.23B
| $284K | ﹤0.01% |
+61,534
| New | +$245K |
|
|
SCPH
3220
DELISTED
scPharmaceuticals
SCPH
| $279K | ﹤0.01% |
105,935
+3,081
| +3% | +$10K |
|
3221
AudioEye
AEYE
$74.2M
| $277K | ﹤0.01% |
24,979
+2,618
| +12% | +$39.5K |
|
|
SVCO
3222
Silvaco Group
SVCO
$278M
| $277K | ﹤0.01% |
60,724
+4,667
| +8% | +$31.9K |
|
3223
Foghorn Therapeutics
FHTX
$287M
| $276K | ﹤0.01% |
75,495
| – | – |
|
3224
ADC Therapeutics
ADCT
$136M
| $274K | ﹤0.01% |
194,258
| – | – |
|
3225
Nkarta
NKTX
$157M
| $271K | ﹤0.01% |
147,551
+22,538
| +18% | +$46.2K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.